We then tested these ASOs in KRAS mutant-bearing cancer cell lines, including A427 (KRAS G12D) and H441 (KRAS G12V) human lung cancer cells, to examine the specific knockdown of KRAS by the ASO-loaded EVs. This evidence concerns the gene KRAS and lung carcinoma.